166 related articles for article (PubMed ID: 37632669)
1. Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer.
Zhang C; Ni X; Tao C; Zhou Z; Wang F; Gu F; Cui X; Jiang S; Li Q; Lu H; Li D; Wu Z; Zhang R
Cell Oncol (Dordr); 2024 Feb; 47(1):157-174. PubMed ID: 37632669
[TBL] [Abstract][Full Text] [Related]
2. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
3. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
Han J; Hu X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
[TBL] [Abstract][Full Text] [Related]
5. MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism.
Fang Y; Yu H; Zhou H
Biochem Biophys Res Commun; 2022 Apr; 598():47-54. PubMed ID: 35151203
[TBL] [Abstract][Full Text] [Related]
6. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer.
Zhang J; Zhang J; Wang F; Xu X; Li X; Guan W; Men T; Xu G
J Cell Physiol; 2021 Oct; 236(10):6907-6919. PubMed ID: 33655494
[TBL] [Abstract][Full Text] [Related]
8. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
Ma N; Zhao Y
Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
[TBL] [Abstract][Full Text] [Related]
9. LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.
Chen L; Qian J; You Q; Ma J
Bioengineered; 2021 Dec; 12(2):10089-10100. PubMed ID: 34724866
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Chen XJ; An N
J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
13. Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184.
Hou W; Zhang Y
Pathol Res Pract; 2021 Jan; 217():153275. PubMed ID: 33285422
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein.
Zhang M; Xu Y; Zhang Y; Li B; Lou G
Cell Signal; 2021 Aug; 84():110014. PubMed ID: 33894314
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of circular RNA circ‑FAM53B predicts adverse prognosis and accelerates the progression of ovarian cancer via the miR‑646/VAMP2 and miR‑647/MDM2 signaling pathways.
Sun D; Liu J; Zhou L
Oncol Rep; 2019 Dec; 42(6):2728-2737. PubMed ID: 31638250
[TBL] [Abstract][Full Text] [Related]
17. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
19. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C.
Xu N; Ren Y; Bao Y; Shen X; Kang J; Wang N; Wang Z; Han X; Li Z; Zuo J; Wei GH; Wang Z; Zong WX; Liu W; Xie G; Wang Y
Cell Rep; 2023 Sep; 42(9):113041. PubMed ID: 37682709
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
